BiomarkersHumans
From zero to 6,000 in 9 months: Recruitment and innovation strategies for a remote longitudinal Alzheimer's population‐based screening study – Insights from the REAL AD study
AAIC 2025 Abstract
Abstract
Background: The REAL AD study aims to validate the diagnostic and prognostic performance of combining blood‐based biomarkers and remote cognitive testing as a screening approach for early Alzheimer's disease (AD), leveraging an existing healthcare infrastructure in Western Sweden.
The paper
Iris Bosch, Frida Lenér, Laura S Stankeviciute, Michael Schöll
Show 9 more authors
Ellen H. Singleton, Fredrik Öhman, Kajsa Quitz, Maria Greca Dottori, David Berron, Nicolai Franzmeier, Silke Kern, Henrik Zetterberg, Kaj Blennow,Sahlgrenska University Hospital
AAIC 2025 Abstract · 23 Dec 2025 · CC BY
Presented at AAIC 2025
